Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor
Ontology highlight
ABSTRACT: The study is a Phase 1 Open-label Two-stage, Safety and Tolerability Study with Cancer Type-specific Cohorts, Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients with Advanced Solid Tumors that are Refractory to Standard Therapy or For Which No Standard Therapy Is Available. Patients with unresectable solid tumors that are refractory or have failed standard therapy and are deemed non-eligible or intolerant to further therapy or for which no standard therapy is available will be included in 5 cancer type-specific parallel cohorts. The following tumor types will be evaluated for potential inclusion in each cancer type-specific cohort: gallbladder & biliary tract carcinoma; cervical carcinoma; gastric carcinoma; pancreatic carcinoma, and colorectal carcinoma.
DISEASE(S): Tumor, Solid,Solid Tumor,Carcinoma,Cervical Cancer,Gastric Cancer,Colorectal Cancer,Gallbladder Neoplasms,Pancreatic Cancer,Gall Bladder Cancer,Cancer
PROVIDER: 2308250 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA